REPTYROS
Live / Allowed — Fifth extension granted (statement of use) (as of 23 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Feb 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97272831
- Mark type
- Word mark
- Filed
- 17 Feb 2022
- Published for opposition
- 11 Jul 2023
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer
Owner
- Turning Point Therapeutics, Inc., San Diego, CA, US
- Turning Point Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 24 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jun 2026 — SOU EXTENSION 5 GRANTED
- 11 Feb 2026 — SOU EXTENSION 5 FILED
- 23 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 27 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Aug 2025 — SOU EXTENSION 4 GRANTED
- 26 Aug 2025 — SOU EXTENSION 4 FILED
- 26 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2025 — SOU EXTENSION 3 GRANTED
- 04 Mar 2025 — SOU EXTENSION 3 FILED
- 04 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Aug 2024 — SOU EXTENSION 2 GRANTED